Valuation : AroCell AB

Market Cap 93.07M 9.69M 8.34M 7.85M 7.15M 13.39M 922M 13.44M 35.97M 470M 36.39M 35.6M 1.49B P/E 2024
-2.12x
P/E 2025 -6.69x
Enterprise Value 69.73M 7.26M 6.25M 5.88M 5.36M 10.03M 691M 10.07M 26.95M 352M 27.27M 26.67M 1.12B EV / Sales 2024
0.73x
EV / Sales 2025 1.09x
Free-Float
68.85%
Yield 2024 *
-
Yield 2025 -
1 day-0.99%
1 week-0.50%
Current month+1.52%
1 month+3.90%
3 months-18.37%
6 months+13.64%
Current year+13.31%
1 week 0.38
Extreme 0.385
0.41
1 month 0.35
Extreme 0.354
0.46
Current year 0.25
Extreme 0.25
0.53
1 year 0.25
Extreme 0.25
0.53
3 years 0.25
Extreme 0.25
0.66
5 years 0.25
Extreme 0.25
2.4
10 years 0.25
Extreme 0.25
8.45
Manager TitleAgeSince
Chief Executive Officer - 28/05/2026
Director of Finance/CFO - 18/08/2022
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 56 01/01/2020
Chairman 39 22/05/2024
Director/Board Member 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/21 A Buy

Executive/Senior Manager

25,000 0.0220%
9/2/21 A Buy 20,000 0.0176%
9/1/21 A Buy

Director

5,353 0.0047%
Change 5-day change 1-year change 3-year change Capi.($)
-0.99%-0.50%-2.44%-24.24% 9.69M
+0.56%-7.04%-2.80%+11.04% 46.38B
+0.17%-0.74%+407.28%+546.58% 44.51B
-0.86%-2.60%+35.51%+20.35% 42.3B
-0.14%-2.98%-0.04%+82.21% 39.91B
0.00%-1.72%+13.42%+42.33% 32.79B
-3.44%-2.43% - - 17.13B
-0.78%-1.13%+20.74%+116.26% 16.36B
-0.39%-3.84%+12.23%+30.38% 14.31B
-0.86%-4.60%+76.86%+39.36% 13.29B
Average -0.68%-2.21%+62.31%+96.03% 26.7B
Weighted average by Cap. -0.37%-3.04%+85.95%+133.00%

Financials

2024 2025
Net sales 57.44M 5.98M 5.15M 4.85M 4.42M 8.26M 569M 8.29M 22.2M 290M 22.46M 21.97M 919M 53.11M 5.53M 4.76M 4.48M 4.08M 7.64M 526M 7.67M 20.53M 268M 20.77M 20.32M 849M
Net income -42.45M -4.42M -3.8M -3.58M -3.26M -6.11M -421M -6.13M -16.41M -214M -16.6M -16.24M -679M -12.15M -1.27M -1.09M -1.03M -934K -1.75M -120M -1.75M -4.7M -61.34M -4.75M -4.65M -194M
Net Debt -47.78M -4.98M -4.28M -4.03M -3.67M -6.87M -474M -6.9M -18.47M -241M -18.69M -18.28M -764M -23.34M -2.43M -2.09M -1.97M -1.79M -3.36M -231M -3.37M -9.02M -118M -9.13M -8.93M -373M
Logo AroCell AB
IDL Diagnostics AB (publ), formerly AroCell AB (publ), is a Sweden-based diagnostic Company engaged in the biotechnology and medical diagnostics industry. The Company focuses on research, development, manufacturing, and commercialization of diagnostic and medical technology products. The Company has a broad product portfolio of In Vitro Diagnostics (IVD) tests that deliver clinical information for the detection of disease with indications spanning everything from urological cancers to typhoid fever. IDL Diagnostics AB (publ) develops tests that are clinically useful and economically viable. The Company provides rapid tests, laboratory tests and platform tests that improve decision making and are non-invasive, cost effective, as well as easy to perform.
Employees
25
Date Price Change Volume
10/09/26 SEK 0.4000 -0.99% 1,000
09/09/26 SEK 0.4040 -1.22% 89,800
08/09/26 SEK 0.4090 +0.49% 657,650
07/09/26 SEK 0.4070 +1.24% 62,735
04/09/26 SEK 0.4020 0.00% 62,769

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IDLDX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!